Dr. Miao is co-founder and Chief Scientific Advisor of AKSO Biopharmaceutical Inc. Prior to founding AKSO Bio, Dr. Miao led the development effort of numerous therapeutic molecules that are currently in clinical trials. She received her doctorate from the University of Melbourne, Australia. In 2010, she joined Professor Giaccia at Stanford University as a research scientist and is directly responsible for the discovery and characterization of DEEP Platform. Dr. Miao has more than 15 years of experience in developing translational therapeutics for the treatment of oncology and other indications with unmet clinical needs. Her discoveries were published in high impact factor journals and resulted in over 30 US and international patents. She is involved in both pre-clinical and clinical development of AKSO Bio’s pipeline.